F. Jotereau

发表

An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context

B. Dréno, Y. Godet, A. Moreau-Aubry, 2010, Cancer Immunology, Immunotherapy.

Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.

N. Marchand-Geneste, F. Jotereau, Céline Douat-Casassus, 2007, Journal of medicinal chemistry.

CD4CD8αα Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

Joe-Marc Chauvin, H. Sokol, K. Asehnoune, 2014, PLoS biology.

Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.

P. Kourilsky, J. Even, M. Favrot, 1994, Journal of immunology.

Cell kinetics in the fetal mouse thymus: precursor cell input, proliferation, and emigration.

F. Heuźe, H. Gascan, F. Jotereau, 1987, Journal of immunology.

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

B. Dréno, Y. Godet, V. Vignard, 2007, Cancer Immunology, Immunotherapy.

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

B. Dréno, A. Khammari, F. Jotereau, 2002, Cancer Immunology, Immunotherapy.

Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells.

C. Sanders, N. Bhardwaj, W. Kwok, 2001, Journal of immunological methods.

Double positive CD4+CD8+ T cells are part of the adaptive immune response against Candida albicans.

P. Le Pape, F. Jotereau, Nidia Alvarez-Rueda, 2019, Human immunology.

[Origin of osteoclasts].

F. Jotereau, 1985, Annales de biologie clinique.

Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

B. Dréno, S. Billaudel, A. Khammari, 2002, Cancer Immunology, Immunotherapy.

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas

B. Dréno, Y. Godet, A. Moreau-Aubry, 2010, PloS one.

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

F. Jotereau, E. Diéz, N. Gervois, 1996, The Journal of experimental medicine.

Implications for Adoptive Immunotherapy Lymphocytes Is Induced by IL-12: Expression of CD94/NKG2-A on Human T

F. Jotereau, E. Diéz, L. Derré, 2002 .

Human Tumor-Reactive T Cells Required for Efficient Cross-Priming of HLA-A2 Epitope within a Long Peptide Is - HLA Anchor Optimization of the Melan-A

Joe-Marc Chauvin, F. Jotereau, N. Labarrière, 2012 .

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

F. Jotereau, N. Labarrière, N. Gervois, 2012, Targeted Oncology.

Frequent occurrence of high affinity T cells against MELOE‐1 makes this antigen an attractive target for melanoma immunotherapy

D. Schadendorf, B. Dréno, Y. Godet, 2010, European journal of immunology.

A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes

B. Dréno, A. Khammari, F. Lang, 2009, Cancer Immunology, Immunotherapy.

PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting

F. Lang, F. Jotereau, N. Labarrière, 2007, Cancer Immunology, Immunotherapy.

A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes

Y. Godet, F. Jotereau, P. Larrieu, 2008, Cancer Immunology, Immunotherapy.

TFrequencies of Additional MelanA-Specific Patients Is Followed by Increased MelanA-Specific CTL Clones in Melanoma Adoptive Transfer of Tumor-Reactive Jotereau and

K. Echasserieau, B. Dréno, A. Lim, 2005 .

A ras-Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion1

S. Bézieau, F. Jotereau, N. Labarrière, 2002, The Journal of Immunology.

Comprehensive analysis of the frequency of recognition of melanoma‐associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy

M. Bonneville, F. Jotereau, N. Labarrière, 2001, European journal of immunology.

Immunodominant Peptide Analogues CTL In Vitro by Selected Melan-A/MART-1 Enhanced Generation of Specific Tumor-Reactive

D. Valmori, F. Jotereau, J. Cerottini, 2017 .

Antigenic Peptide Immunodominant Melan-A/MART-1 HLA-A*0201-Restricted CTL Specific for the Diversity of the Fine Specificity Displayed by

P. Romero, D. Valmori, F. Jotereau, 1998 .

Human CD4 + CD8α + Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation

H. Sokol, J. Chatel, P. Langella, 2022 .

Tissue distribution and ontogenic appearance of a chicken T lymphocyte differentiation marker

F. Jotereau, E. Houssaint, E. Diéz, 1985, European journal of immunology.

Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction

H. Sokol, C. Bridonneau, F. Jotereau, 2019, Front. Immunol..

Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions

F. Jotereau, N. Gervois, L. Derré, 2009, International journal of cancer.

Tumor‐reactive CD4+CD8αβ+ CD103+ αβT cells: A prevalent tumor‐reactive T‐cell subset in metastatic colorectal cancers

F. Jotereau, N. Gervois, G. Sarrabayrouse, 2011, International journal of cancer.

Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.

P. Romero, D. Valmori, F. Jotereau, 1997, Journal of immunology.

Microbiota-Specific CD4CD8αα Tregs: Role in Intestinal Immune Homeostasis and Implications for IBD

F. Jotereau, F. Altare, G. Sarrabayrouse, 2015, Front. Immunol..

CD 4 CD 8 aa Lymphocytes , A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease

Joe-Marc Chauvin, H. Sokol, K. Asehnoune, 2014 .

Molecular analysis of a pro‐T cell clone transformed by Abelson‐murine leukemia virus, displaying progressive γδ T cell receptor gene rearrangement and surface expression

D. Pardoll, F. Heuźe, F. Jotereau, 1992, European journal of immunology.

Demonstration of a cyclic renewal of the lymphocyte precursor cells in the quail thymus during embryonic and perinatal life.

F. Jotereau, N. L. Le Douarin, 1982, Journal of immunology.

Covalent modification of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies.

N. Marchand-Geneste, M. Bourguet-Kondracki, F. Jotereau, 2006, Molecular bioSystems.

Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.

H. Sokol, E. Montassier, A. Jarry, 2018, Gastroenterology.

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

C. Volteau, B. Dréno, A. Khammari, 2007, Cancer Immunology, Immunotherapy.

Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles.

L. Old, D. Valmori, F. Jotereau, 2006, Clinical immunology.

HLA class II‐restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma‐infiltrating lymphocytes

B. Dréno, F. Jotereau, E. Diéz, 1995, European journal of immunology.

Self-Antigen Specific for a Human Tumor-Associated Selection of the Preimmune Repertoire-Chain in the α Prevalent Role of TCR Cerottini

M. Bonneville, P. Romero, P. Coulie, 2003 .

Apoptotic body–loaded dendritic cells efficiently cross‐prime cytotoxic T lymphocytes specific for NA17‐A antigen but not for Melan‐A/MART‐1 antigen

F. Lang, F. Jotereau, N. Labarrière, 2002, International journal of cancer.

Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1

F. Jotereau, E. Diéz, N. Gervois, 2002, The Journal of Immunology.

Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma.

B. Dréno, F. Jotereau, P. Litoux, 1996, European journal of cancer.

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

D. Speiser, P. Romero, V. Cerundolo, 1999, International immunology.

Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells1

M. Bonneville, J. Mosnier, A. Moreau-Aubry, 2005, The Journal of Immunology.

V gamma 9V delta 2 T cell response to colon carcinoma cells.

M. Bonneville, J. Mosnier, A. Moreau-Aubry, 2005, Journal of immunology.

Tumor-Infiltrating Lymphocytes Antigens , Spontaneously Recognized by from Common Melanoma-Associated HLA-B * 3501-Restricted Epitopes Derived Identification of Five New Dreno

B. Dréno, A. Moreau-Aubry, F. Jotereau, 2003 .

High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.

B. Dréno, F. Jotereau, N. Labarrière, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation

H. Vié, F. Jotereau, E. Diéz, 1999, Bone Marrow Transplantation.

Expression and Release of HLA-E by Melanoma Cells and Melanocytes: Potential Impact on the Response of Cytotoxic Effector Cells1

A. Moreau, A. Moreau-Aubry, F. Jotereau, 2006, The Journal of Immunology.

Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98) on renal carcinoma cell lines recognized by a Vγ3Vδ1+ T‐cell clone

W. Urba, A. Moreau, C. Pourcel, 1999 .

Folding of Matrix Metalloproteinase-2 Prevents Endogenous Generation of MHC Class-I Restricted Epitope

F. Jotereau, P. Larrieu, F. Fleury, 2010, PloS one.

Human monocyte‐derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I‐restricted exogenous peptides

J. Delcros, F. Jotereau, G. Corradin, 1997, Immunology.

Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangements

F. Heuźe, F. Jotereau, E. Diéz, 1990, European journal of immunology.

Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma‐infiltrating lymphocytes

C. Viret, F. Jotereau, E. Diéz, 1992, European journal of immunology.

High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human T-lymphocyte clone derived from tumor-infiltrating lymphocytes.

F. Heuźe, F. Jotereau, E. Diéz, 1990, Human immunology.

Activation of tumor‐specific T cells by dendritic cells expressing the NY‐ESO‐1 antigen after transfection with the cationic lipophosphoramide KLN5

P. Delépine, T. Montier, P. Lehn, 2008, The journal of gene medicine.

Recognition of shared melanoma antigen by HLA‐A2‐restricted cytolytic T cell clones derived from human tumor‐infiltrating lymphocytes

C. Viret, F. Jotereau, R. Breathnach, 1993, European journal of immunology.

Tracing of cells of the avian thymus through embryonic life in interspecific chimeras

F. Jotereau, N. L. Le Douarin, 1975, The Journal of experimental medicine.

Peptides derived from the protein mmp-2 and their use in antitumor immunotherapy

F. Jotereau, E. Diéz, Y. Guilloux, 2003 .

Defective lymphokine production by most CD8+ and CD4+ tumor‐specific T cell clones derived from human melanoma‐infiltrating lymphocytes in response to autologous tumor cells in vitro

C. Viret, F. Jotereau, E. Diéz, 1994, European journal of immunology.

A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes

F. Jotereau, P. Larrieu, J. Fonteneau, 2007, Cancer Immunology, Immunotherapy.

Evidence for a cyclic renewal of lymphocyte precursor cells in the embryonic chick thymus.

F. Jotereau, M. Coltey, N. L. Le Douarin, 1987, Cell differentiation.

Ontogeny of Avian Lymphocytes

F. Jotereau, E. Houssaint, N. Douarin, 1982 .

The developmental relationship between osteocytes and osteoclasts: A study using the quail-chick nuclear marker in endochondral ossification☆

F. Jotereau, N. L. Le Douarin, 1978 .

Differentiation of the primary lymphoid organs in avian embryos: origin and homing of the lymphoid stem cells.

F. Jotereau, E. Houssaint, N. L. Le Douarin, 1977, Advances in experimental medicine and biology.

Origin and renewal of lymphocytes in avian embryo thymuses studied in interspecific combinations.

F. Jotereau, N. Ledouarin, 1973, Nature: New biology.

Relationship between thymus ontogeny and DNA ligase expression in the chicken

F. Jotereau, J. David, D. Maniey, 1987, European journal of immunology.

Impact on the Response of Cytotoxic Effector Melanoma Cells and Melanocytes : Potential Expression and Release of HLA-E by Francine Jotereau and

A. Moreau, A. Moreau-Aubry, F. Jotereau, 2006 .

Lymphoid stem cell homing to the early thymic primordium of the avian embryo

F. Jotereau, E. Houssaint, N. L. Le Douarin, 1980, European journal of immunology.

Fucose and galactose receptor and liver recognition by lymphoma cells

F. Heuźe, F. Jotereau, K. Méflah, 1990, International journal of cancer.

Subopt imal Activation o f Melanoma Infiltrating Lymphocytes ( TIL ) due to Low Avidity

F. Jotereau, E. Diéz, N. Gervois, 2003 .

High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.

B. Dréno, J. Douillard, F. Jotereau, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions

R. Teusan, F. Jotereau, F. Altare, 2022, Frontiers in Immunology.

Avian Embryos in Immunology

J. Richard, F. Jotereau, E. Houssaint, 1985 .

Origin of hemopoietic stem cells in embryonic bursa of Fabricius and bone marrow studied through interspecific chimeras.

F. Jotereau, E. Houssaint, N. L. Le Douarin, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Concomitant decrease of double-positive lymphocyte population CD4CD8αα and Faecalibacterium prausnitzii in patients with colorectal cancer.

M. Rimbert, F. Javaudin, E. Montassier, 2020, European journal of gastroenterology & hepatology.

Ontogeny of the avian thymus and bursa of Fabricius studied in interspecific chimeras.

F. Jotereau, E. Houssaint, N. L. Le Douarin, 1976, Annales d'immunologie.

Long‐lasting cross‐presentation of tumor antigen in human DC

F. Faure, Charlotte Sadaka, C. Sedlik, 2009, European journal of immunology.

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N- acetylglucosaminyltransferase V gene

F. Brasseur, C. Viret, T. Boon, 1996, The Journal of experimental medicine.

Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.

M. Bonneville, A. Moreau, A. Moreau, 1995, Journal of immunology.

A Spliced Antigenic Peptide Comprising a Single Spliced Amino Acid Is Produced in the Proteasome by Reverse Splicing of a Longer Peptide Fragment followed by Trimming

A. Moreau-Aubry, F. Jotereau, B. J. Van den Eynde, 2014, The Journal of Immunology.

Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses.

B. Pulendran, M. Merad, Navpreet Tung, 2014, Cell reports.

Activation of Toll-like Rec eptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses Graphical

B. Pulendran, M. Merad, Navpreet Tung, 2014 .

A Processed Pseudogene Codes for a New Antigen Recognized by a Cd8+ T Cell Clone on Melanoma

A. Moreau-Aubry, F. Jotereau, N. Labarrière, 2000, The Journal of experimental medicine.

HLA‐E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression

C. Volteau, J. Mosnier, S. Bézieau, 2012, International journal of cancer.

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

P. Romero, D. Valmori, F. Jotereau, 1998, Journal of immunology.

The cancer germ‐line genes MAGE‐1, MAGE‐3 and PRAME are commonly expressed by human myeloma cells

R. Bataille, C. Pellat-deceunynck, G. Jego, 2000, European journal of immunology.

Dominant TCR Vα usage by virus and tumor‐reactive T cells with wide affinity ranges for their specific antigens

M. Bonneville, L. Trautmann, P. Coulie, 2002, European journal of immunology.

Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.

B. Baker, F. Jotereau, O. Borbulevych, 2010, Journal of medicinal chemistry.

Peptides flush mutes and their use in immunotherapy

F. Jotereau, N. Labarrière, E. Diéz, 2002 .

Infiltrating a Human Melanoma Lesion Mutated Peptide Targeted by CTL ras- A

S. Bézieau, F. Jotereau, N. Labarrière, 2017 .

Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases

Eric Vivier, Francine Jotereau, G. Krystal, 1998, European journal of immunology.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

R M Zinkernagel, P. Klenerman, R. Zinkernagel, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting.

M. Monsigny, E. Duverger, A. Roche, 2007, Bioconjugate chemistry.

Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway.

L. Rolnitzky, B. Dréno, J. Goldberg, 2011, Cancer cell.

Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells1

K. Echasserieau, B. Dréno, A. Lim, 2005, The Journal of Immunology.

Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.

B. Dréno, C. Viret, F. Jotereau, 1997, Journal of immunology.

Peptide Fragment followed by Trimming Proteasome by Reverse Splicing of a Longer theSingle Spliced Amino Acid Is Produced in A Spliced Antigenic Peptide Comprising a den Eynde

A. Moreau-Aubry, F. Jotereau, B. Eynde, 2014 .

αvβ3-dependent cross-presentation of matrix metalloproteinase–2 by melanoma cells gives rise to a new tumor antigen

B. Dréno, A. Moreau-Aubry, F. Jotereau, 2005, The Journal of experimental medicine.

High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

Francine Jotereau, B. Dréno, F. Jotereau, 2001, Cancer Immunology, Immunotherapy.

Frequency and relative fraction of tumor antigen‐specific T cells among lymphocytes from melanoma‐invaded lymph nodes

B. Dréno, F. Jotereau, N. Labarrière, 1998, International Journal of Cancer.

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

B. Dréno, V. Vignard, A. Khammari, 2009, The Journal of investigative dermatology.

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency

B. Dréno, Y. Godet, A. Moreau-Aubry, 2008, The Journal of experimental medicine.

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

D. Schadendorf, B. Dréno, Y. Godet, 2009, Cancer Immunology, Immunotherapy.

Prevalent Role of TCR α-Chain in the Selection of the Preimmune Repertoire Specific for a Human Tumor-Associated Self-Antigen1

M. Bonneville, P. Romero, P. Coulie, 2003, The Journal of Immunology.

Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.

P. Romero, D. Valmori, F. Jotereau, 1998, Journal of immunology.

LFA‐3 co‐stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR‐independent activation signal

C. Viret, F. Jotereau, N. Labarrière, 1998, European journal of immunology.

Identification of Five New HLA-B*3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes 1

Francine Jotereau, Elisabeth Diez, B. Dréno, 2003, The Journal of Immunology.

Cross-Presentation of Synthetic Long Peptides by Human Dendritic Cells: A Process Dependent on ERAD Component p97/VCP but Not sec61 and/or Derlin-1

P. Kloetzel, S. Nedellec, E. Duverger, 2014, PloS one.

Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA‐A*0201‐restricted epitopes

F. Lemonnier, I. Miconnet, J. Abastado, 2004, International journal of cancer.

HLA Anchor Optimization of the Melan-A–HLA-A2 Epitope within a Long Peptide Is Required for Efficient Cross-Priming of Human Tumor-Reactive T Cells

Joe-Marc Chauvin, F. Jotereau, N. Labarrière, 2012, The Journal of Immunology.

Cells 2 T Cell Response to Colon Carcinoma δ 9V γ V

Marc Bonneville, Francine Jotereau, Jaafar Bennouna, 2013 .

Cells 2 T Cell Response to Colon Carcinoma d 9V g V

M. Bonneville, J. Mosnier, A. Moreau-Aubry, 2005 .

Heterogeneity of biologic responses of melanoma-specific CTL.

F. Jotereau, E. Diéz, N. Gervois, 1997, Journal of immunology.

Human CD4+/CD8α+ regulatory T cells induced by Faecalibacterium prausnitzii protect against intestinal inflammation

H. Sokol, J. Chatel, P. Langella, 2022, bioRxiv.

Microbiota-induced regulatory T cells associate with FUT2-dependent susceptibility to rotavirus gastroenteritis

J. Chatel, J. Le Pendu, T. Carton, 2023, Frontiers in Microbiology.

Cytogenetics of Abelson virus-induced malignant lymphoma cell lines in the mouse.

F. Heuźe, F. Jotereau, E. Diéz, 1987, Cancer genetics and cytogenetics.

Human CD4+/CD8α+ regulatory T cells induced by Faecalibacterium prausnitzii protect against intestinal inflammation.

H. Sokol, J. Chatel, P. Langella, 2022, JCI insight.